Reporting Manager
GordonMD Global Investments LP
Symbol
KYTX
Shares outstanding
43,692,643 shares
Disclosed Ownership
3,058,485 shares
Ownership
7%
Form type
SCHEDULE 13G
Filing time
17 Nov 2025, 15:41:11 UTC
Date of event
13 Nov 2025

Quoteable Key Fact

"GordonMD Global Investments LP disclosed 7% ownership in Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX) on 13 Nov 2025."

Quick Takeaways

  • GordonMD Global Investments LP filed SCHEDULE 13G for Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share (KYTX).
  • Disclosed ownership: 7%.
  • Date of event: 13 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 17 Nov 2025, 15:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
GordonMD Global Investments LP 7% 3,058,485 0 3,058,485 /s/ GordonMD Global Investments GP LLC Craig D. Gordon / Managing Member of the General Partner
GordonMD Long Biased Master Fund LP 6.2% 2,735,783 0 2,735,783 /s/ GordonMD Long Biased GP LLC GordonMD Long Biased GP LLC / Managing Member of the General Partner
GordonMD Long Biased GP LLC 6.2% 2,735,783 0 2,735,783 /s/ Craig D. Gordon Craig D. Gordon / Managing Member
Craig D. Gordon 7% 3,058,485 0 3,058,485 /s/ Craig D. Gordon Craig D. Gordon
GordonMD Global Investments GP LLC 7% 3,058,485 0 3,058,485 /s/ Craig D. Gordon Craig D. Gordon / Managing Member